These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 9260753)

  • 1. Reticulocyte hemoglobin: an integrated parameter for evaluation of erythropoietic activity.
    Brugnara C; Zelmanovic D; Sorette M; Ballas SK; Platt O
    Am J Clin Pathol; 1997 Aug; 108(2):133-42. PubMed ID: 9260753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of intravenous iron on the reticulocyte response to recombinant human erythropoietin.
    Major A; Mathez-Loic F; Rohling R; Gautschi K; Brugnara C
    Br J Haematol; 1997 Aug; 98(2):292-4. PubMed ID: 9266922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reticulocyte parameters as potential discriminators of recombinant human erythropoietin abuse in elite athletes.
    Parisotto R; Gore CJ; Hahn AG; Ashenden MJ; Olds TS; Martin DT; Pyne DB; Gawthorn K; Brugnara C
    Int J Sports Med; 2000 Oct; 21(7):471-9. PubMed ID: 11071048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of hydroxyurea on immature reticulocyte fraction in sickle cell anemia.
    Bagdasaryan R; Glasser L; Quillen K; Chaves F; Xu D
    Lab Hematol; 2007; 13(3):93-7. PubMed ID: 17984040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reticulocyte cellular indices: a new approach in the diagnosis of anemias and monitoring of erythropoietic function.
    Brugnara C
    Crit Rev Clin Lab Sci; 2000 Apr; 37(2):93-130. PubMed ID: 10811141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reticulocyte hemoglobin content.
    Mast AE; Blinder MA; Dietzen DJ
    Am J Hematol; 2008 Apr; 83(4):307-10. PubMed ID: 18027835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemoglobinization and functional availability of iron for erythropoiesis in case of thalassemia and iron deficiency anemia.
    Bartels PC; Schoorl M; Schoorl M
    Clin Lab; 2006; 52(3-4):107-14. PubMed ID: 16584056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of reticulocyte cellular indices in the diagnosis and treatment of hematological disorders.
    Brugnara C
    Int J Clin Lab Res; 1998; 28(1):1-11. PubMed ID: 9594357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum transferrin receptor as a marker of erythropoiesis suppression in patients on chronic transfusion.
    Tancabelic J; Sheth S; Paik M; Piomelli S
    Am J Hematol; 1999 Feb; 60(2):121-5. PubMed ID: 9929103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reticulocyte hemoglobin equivalent: an indicator of reduced iron availability in chronic kidney diseases during erythropoietin therapy.
    Garzia M; Di Mario A; Ferraro E; Tazza L; Rossi E; Luciani G; Zini G
    Lab Hematol; 2007; 13(1):6-11. PubMed ID: 17353176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reference values and hematologic changes from birth to 5 years in patients with sickle cell disease. Cooperative Study of Sickle Cell Disease.
    Brown AK; Sleeper LA; Miller ST; Pegelow CH; Gill FM; Waclawiw MA
    Arch Pediatr Adolesc Med; 1994 Aug; 148(8):796-804. PubMed ID: 7519102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of subcutaneous recombinant human erythropoietin in normal subjects: development of decreased reticulocyte hemoglobin content and iron-deficient erythropoiesis.
    Brugnara C; Colella GM; Cremins J; Langley RC; Schneider TJ; Rutherford CJ; Goldberg MA
    J Lab Clin Med; 1994 May; 123(5):660-7. PubMed ID: 8195672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reticulocyte parameters and hemoglobin F production in sickle cell disease patients undergoing hydroxyurea therapy.
    Borba R; Lima CS; Grotto HZ
    J Clin Lab Anal; 2003; 17(2):66-72. PubMed ID: 12640630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.
    Rodgers GP; Dover GJ; Uyesaka N; Noguchi CT; Schechter AN; Nienhuis AW
    N Engl J Med; 1993 Jan; 328(2):73-80. PubMed ID: 7677965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoiesis activity, iron availability and reticulocyte hemoglobinization during treatment with hemodialysis and in subjects with uremia.
    Schoorl M; Schoorl M; Nubé MJ; Bartels PC
    Clin Lab; 2006; 52(11-12):621-9. PubMed ID: 17175894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece.
    Loukopoulos D; Voskaridou E; Kalotychou V; Schina M; Loutradi A; Theodoropoulos I
    Blood Cells Mol Dis; 2000 Oct; 26(5):453-66. PubMed ID: 11112383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxyurea therapy in thalassemia.
    Loukopoulos D; Voskaridou E; Stamoulakatou A; Papassotiriou Y; Kalotychou V; Loutradi A; Cozma G; Tsiarta H; Pavlides N
    Ann N Y Acad Sci; 1998 Jun; 850():120-8. PubMed ID: 9668534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection of response to hydroxyurea therapy in patients with sickle cell anemia.
    Ballas SK; McCarthy WF; Guo N; Brugnara C; Kling G; Bauserman RL; Waclawiw MA
    Hemoglobin; 2010; 34(5):424-9. PubMed ID: 20854115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietic activity in patients with sickle cell anaemia before and after treatment with hydroxyurea.
    Ballas SK; Marcolina MJ; Dover GJ; Barton FB
    Br J Haematol; 1999 May; 105(2):491-6. PubMed ID: 10233426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrepancy between the percentage of hypochromic erythrocytes and the reticulocyte hemoglobin content in hemodialysis patients with recombinant human erythropoietin therapy.
    Asanuma M; Taguchi C; Uesaka H; Kumagai T; Seino K; Hosokawa H; Yamauchi F; Fujishima M; Murai K; Ishida Y
    Lab Hematol; 2005; 11(2):124-30. PubMed ID: 16024336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.